RAC 2.92% $1.94 race oncology ltd

Ann: Updated Strategy and Investor Presentation, page-73

  1. 141 Posts.
    lightbulb Created with Sketch. 642
    Thanks for your insights DGener8, more than happy to be corrected. Out of curiosity, are the bulk of these echos done transthoracically? I would assume so, so perhaps I've overestimated the invasiveness. I'm also assuming you're based in AU, do you know if practice in the US is similar?

    I guess the more important aspect as you have pointed out is that LVEF and GLT are poorer indicators of functional capacity according to the presentation.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.